false
Catalog
E-Posters
10162_Zinkgraf
10162_Zinkgraf
Back to course
Pdf Summary
This study aimed to determine if topical lidocaine during urodynamic testing (UDS) reduces patient discomfort and if it affects UDS results. The participants were women with stress urinary incontinence scheduled for UDS. The intervention group received lidocaine while the control group received plain lubricating gel. Data collection included a bladder diary and a distress inventory. Pain levels were measured using a Likert scale at four time points during UDS. The study found that total pain in the lidocaine group was significantly lower than in the control group, and pain was consistently lower in the lidocaine group at all measured time points. Lidocaine did not alter UDS results compared to the maximum voided volume on the bladder diary. <br /><br />In conclusion, 2% topical lidocaine administered transurethrally 10 minutes before UDS decreased pain without affecting the UDS results. The study recommends routinely administering lidocaine prior to UDS to reduce the pain caused by the catheter. Further studies should assess if pain reduction during UDS leads to more accurate results and reduces false negative results. Topical lidocaine is an inexpensive and readily available option for reducing discomfort during UDS.
Keywords
topical lidocaine
urodynamic testing
patient discomfort
UDS results
women
stress urinary incontinence
bladder diary
distress inventory
pain levels
Likert scale
×
Please select your language
1
English